These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15714761)

  • 41. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
    Marchais D; Bockaert J
    Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
    [No Abstract]   [Full Text] [Related]  

  • 42. Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
    Mottola DM; Kilts JD; Lewis MM; Connery HS; Walker QD; Jones SR; Booth RG; Hyslop DK; Piercey M; Wightman RM; Lawler CP; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1166-78. PubMed ID: 12023552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of chronic ethanol treatment on adenylate cyclase activity in rat striatum.
    Lucchi L; Covelli V; Anthopoulou H; Spano PF; Trabucchi M
    Neurosci Lett; 1983 Sep; 40(2):187-92. PubMed ID: 6314211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition by beta-endorphin of dopamine-sensitive adenylate cyclase in rat striatum.
    Motomatsu T; Lis M; Seidah N; Chrétien M
    Biochem Biophys Res Commun; 1977 Jul; 77(1):442-7. PubMed ID: 883988
    [No Abstract]   [Full Text] [Related]  

  • 45. Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain.
    Karobath ME
    Eur J Pharmacol; 1974 Oct; 28(2):376-8. PubMed ID: 4424404
    [No Abstract]   [Full Text] [Related]  

  • 46. Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.
    Memo M; Lovenberg W; Hanbauer I
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4456-60. PubMed ID: 6956874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased spontaneous motor activity parallels reserpine-induced supersensitivity of catecholamine-responsive rat cerebral cortex adenylate cyclase.
    Wagner HR; Palmer GC; Hall TL; Putnam RW
    Behav Biol; 1978 Jun; 23(2):225-9. PubMed ID: 678261
    [No Abstract]   [Full Text] [Related]  

  • 49. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 1991 Sep; 202(2):273-6. PubMed ID: 1839386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of somatostatin on adenylate cyclase as functional correlate for different brain somatostatin receptor subpopulations.
    Markstein R; Stöckli KA; Reubi JC
    Neurosci Lett; 1989 Sep; 104(1-2):13-8. PubMed ID: 2573010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors.
    Bockaert J; Premont J; Glowinski J; Thierry AM; Tassin JP
    Brain Res; 1976 May; 107(2):301-15. PubMed ID: 1268730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.
    Rosenfeld MR; Makman MH; Ahn HS; Thal LJ; Mishra RK; Katzman R
    Adv Biochem Psychopharmacol; 1980; 23():83-93. PubMed ID: 6249092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.
    Roufogalis BD; Thornton M; Wade DN
    Life Sci; 1976 Sep; 19(6):927-34. PubMed ID: 966971
    [No Abstract]   [Full Text] [Related]  

  • 54. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 56. GRF is a highly potent activator of adenylate cyclase in the normal human, bovine and rat pituitary: interaction with somatostatin.
    Reyl-Desmars F; Baird A; Zeytin FN
    Biochem Biophys Res Commun; 1985 Mar; 127(3):977-85. PubMed ID: 2859017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrastructural demonstration of adenylate cyclase activity in the rat neostriatum.
    Panula P; Rechardt L
    Neuroscience; 1979; 4(6):779-88. PubMed ID: 481749
    [No Abstract]   [Full Text] [Related]  

  • 58. Changes in the striatal adenylate cyclase activity following acute and chronic morphine treatment and during withdrawal.
    Puri SK; Volicer L; Cochin J
    J Neurochem; 1976 Dec; 27(6):1551-4. PubMed ID: 1033988
    [No Abstract]   [Full Text] [Related]  

  • 59. Multiple receptors for dopamine.
    Kebabian JW; Calne DB
    Nature; 1979 Jan; 277(5692):93-6. PubMed ID: 215920
    [No Abstract]   [Full Text] [Related]  

  • 60. Guanine nucleotides regulate the effect of substance P on striatal adenylate cyclase of the rat.
    Moser A
    Biochem Biophys Res Commun; 1990 Feb; 167(1):211-5. PubMed ID: 1690002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.